Skip to main content

AusPAR: Certolizumab

Australian Public Assessment Report
Device/Product Name
Cimzia
Active ingredients
Certolizumab
AusPAR Date
Published
Submission Number
PM-2013-00286-2-3
Submission Type
Extension of indications
Decision
Approved

Help us improve the Therapeutic Goods Administration site